Cabaletta Bio
Developing engineered T cell therapies
- B2B
About Cabaletta Bio
Clinical-stage biotechnology developing engineered T cell therapies for autoimmune diseases, seeking deep and durable treatment for patients Headquarters in Philadelphia, PA
Key facts
- Industry
- Biotechnology Research
- Company size
- 51–250 employees
- Headquarters
- Philadelphia, Pennsylvania, United States
- Founded
- 2017
- Revenue
- $21.4M – $169MTamtam estimate
- Website
- cabalettabio.com
Cabaletta Bio at a glance
Cabaletta Bio is a B2B company in the Biotechnology Research industry, headquartered in Philadelphia, Pennsylvania, United States.
Cabaletta Bio was founded in 2017.
Cabaletta Bio has 51–250 employees.
Cabaletta Bio's revenue is $21.4M – $169M (Tamtam estimate).
Selling to companies like Cabaletta Bio?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies